Search
for

    Sort by

    Research

    270-300 / 1000+ results

      research Topical Minoxidil

      11 citations , September 1988 in “Annals of Plastic Surgery”
      Topical minoxidil can help some men regrow hair, but results vary and may decline after a year.
      Metabolic Syndrome: Clinical and Pathophysiological Features and Treatment Options

      research Metabolic syndrome

      February 2005 in “Journal of The American Academy of Dermatology”
      Metabolic syndrome can cause serious health issues and should be considered when treating women with severe acne.
      Minoxidil

      research Minoxidil

      October 2015 in “Elsevier eBooks”
      Minoxidil is effective for hair growth and safe for long-term use.
      Polycystic Ovary Syndrome: Diagnosis and Treatment

      research Polycystic Ovary Syndrome: Diagnosis and Treatment

      73 citations , February 2007 in “The American Journal of Medicine”
      PCOS is a common hormonal disorder in women, treated with lifestyle changes and medications like hormonal contraceptives and metformin.

      research Misoprostol Therapeutics Revisited

      64 citations , January 2001 in “Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy”
      Misoprostol has many medical benefits, including protecting against injuries, aiding in disease treatment, and improving drug effects.
      The Endocrinology of Baldness

      research The endocrinology of baldness

      19 citations , April 2014 in “Hormones”
      Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.
      Botulinum Toxin: Pearls and Pitfalls

      research Botulinum toxin: Pearls & pitfalls

      February 2005 in “Journal of The American Academy of Dermatology”
      Doctors should recognize various nail disorders, new allergens, and metabolic syndrome in patients, and use botulinum toxin carefully in aesthetic procedures.
      Medicine Update

      research Medicine Update

      February 2024 in “IJCP”
      The CDC reports 23 measles cases in unvaccinated US kids, new treatments for eosinophilic esophagitis and osteopenia are approved, poor sleep may cause migraines, atopic dermatitis could lead to asthma, migraines might increase Crohn's disease risk, cancer may raise heart disease risk, gout is linked to prostate issues, Cabo Verde is malaria-free, social factors and vitamin D affect dementia risk, smoking increases hair loss risk, certain drugs might lower thyroid disease risk in arthritis, noma is a neglected disease, and meal timing could impact heart health.
      Spironolactone

      research Spironolactone

      February 2024 in “Practical Diabetes”
      Spironolactone helps reduce hospital visits and death from heart issues, lowers blood pressure, but has unclear effects on heart failure with normal heart pump function and can cause high potassium and breast enlargement in men.
      Polycystic Ovary Syndrome: Symptoms, Risks, and Treatments

      research Polycystic Ovary Syndrome

      December 2015 in “Kosin Medical Journal”
      PCOS treatment should address both symptoms and metabolic risks, starting with lifestyle changes and possibly including medication.
      The Cochrane Database of Systematic Reviews - Issue 8 2012

      research The Cochrane Database of Systematic Reviews - Issue 8 2012

      August 2012 in “Journal of Evidence-Based Medicine”
      The issue included new and updated reviews on various health interventions, with significant findings on weight loss, psychological therapies, cancer treatment, and more.
      Update on Polycystic Ovary Syndrome

      research Update on Polycystic Ovary Syndrome

      October 2016 in “Journal of the Dermatology Nurses’ Association”
      Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.
      Androgenetic Alopecia: A Review and Emerging Treatments

      research Androgenetic Alopecia: a Review and Emerging Treatments

      1 citations , July 2017 in “Clinical research in dermatology”
      Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.
      Male Androgenetic Alopecia

      research Male Androgenetic Alopecia — Endotext

      January 2000
      Male androgenetic alopecia (MAA) is a common, hereditary hair loss condition in men, linked to heart disease, and can be treated with minoxidil, finasteride, or hair transplantation.
      Epidemiology and Treatment of Male Androgenetic Alopecia

      research Epidemiology and Treatment of Male Androgenetic Alopecia

      January 2022 in “Journal of Healthcare Sciences”
      Male Androgenetic Alopecia, a common hair loss in men, can be slowed and partially restored with treatments like minoxidil and finasteride, or hair transplantation. Serenoa repens may be an alternative treatment. More research is needed for new treatments.